CXCL12 and neoplasm: Importantly, D-CAN treatment did not further suppress tumor growth in a-KO and b-KO mice (Supplementary Fig. 2c), suggesting that D-CAN works at least in part through abrogating CXCL12 signaling via ASC ablation.